Human neurocysticercosis, caused by the larval stage of the tapeworm Taenia solium, is an important neurological disorder reported as a major cause of epilepsy. An important risk factor for neurocysticercosis is the presence of human T. solium carriers who, upon open defecation, disseminate tapeworm eggs, which are infective to both humans and pigs. In the latter, infection also results in cysticercosis, with associated health and economic consequences. Control of T. solium therefore, depends greatly on the accurate detection and treatment of carriers. However, the current available direct diagnostic tests depend on the detection, in feces, of either parasite stages or parasite antigens and genetic material. The former are low cost but lack adequate sensitivity and specificity; the latter too expensive to be routinely utilized in endemic communities. Indirect tests based on antibody detection may only show exposure and not active 2 infection. An ideal diagnostic test should be one that is low-cost and is able to quickly and reliably detect tapeworm carriers so appropriate treatment can be prescribed in order to eliminate the source of infection. Such a test remains elusive. Efforts should, therefore, be directed at the formulation of a test that is not only sensitive and specific but also affordable for use in endemic countries.